Treatment patterns from 647 patients with Gaucher disease: An analysis from the Gaucher Outcome Survey

Autor: Deegan, P., Fernandez-Sasso, D., Giraldo, P., Lau, H., Panahloo, Z., Zimran, A.

Publikováno v: In Blood Cells, Molecules and Diseases February 2018 68:218-225

Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label study

Autor: Niven, R., Chung, K.F., Panahloo, Z., Blogg, M., Ayre, G.

Publikováno v: In Respiratory Medicine 2008 102(10):1371-1378

Clinical picture and treatment of 2212 patients with common variable immunodeficiency

Autor: Gathmann, B., Mahlaoui, N., Gerard, L., Oksenhendler, E., Warnatz, K., Schulze, I., Kindle, G., Kuijpers, T.W., Dutch, W.I.D., Beem, R.T. van, Guzman, D., Workman, S., Soler-Palacin, P., Gracia, J., Witte, T. de, Schmidt, R.E., Litzman, J., Hlavackova, E., Thon, V., Borte, M., Borte, S., Kumararatne, D., Feighery, C., Longhurst, H., Helbert, M., Szaflarska, A., Sediva, A., Belohradsky, B.H., Jones, A., Baumann, U., Meyts, I., Kutukculer, N., Wagstrom, P., Galal, N.M., Roesler, J., Farmaki, E., Zinovieva, N., Ciznar, P., Papadopoulou-Alataki, E., Bienemann, K., Velbri, S., Panahloo, Z., Grimbacher, B., Meer, L.T. van der, Deuren, M. van, Netea, M.G., Meer, J.W.M. van der

Publikováno v: Journal of Allergy and Clinical Immunology, 134, 1, pp. 116-26
Journal of allergy and clinical immunology, 134(1), 116-126. Mosby Inc.
Journal of Allergy and Clinical Immunology, 134, 116-26
Journal of Allergy and Clinical Immunology, 134(1), 116

Item does not contain fulltext BACKGROUND: Common variable immunodeficiency (CVID) is an antibody deficiency with an equal sex distribution and a high variability in clinical presentation. The main features include respiratory tract infections and th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b01c463630282d64d9be1c11ddd9f0ef
https://hdl.handle.net/2066/137640

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.